Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Talbot

Showing results (41-50 of 255) with videos related to

Pageof 26
Sort By:
Expert Reviews in Molecular Medicine|July 21, 2010
The role of RNA processing in the pathogenesis of motor neuron degenerationDirk Bäumer, Olaf Ansorge, Mara Almeida, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|May 7, 2024
Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosisLara M Nikel, Kevin Talbot, Björn F Vahsen
Human Molecular Genetics|October 5, 2017
Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscapeMatthew J A Wood, Kevin Talbot, Melissa Bowerman
Journal of Neurology, Neurosurgery, and Psychiatry|September 14, 2021
Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosisAlexander G Thompson, Kevin Talbot, Martin R Turner
Trends in Neurosciences|February 16, 2010
GARS axonopathy: not every neuron's cup of tRNAWilliam W Motley, Kevin Talbot, Kenneth H Fischbeck
Practical Neurology|August 19, 2017
Fundus fluorescein angiography in Susac's syndromeGavin L Reynolds, Kevin Talbot, Srilakshmi M Sharma
Neurology|August 10, 2020
Amyotrophic lateral sclerosis with a heterozygous D91A SOD1 variant and classical ALS-TDP neuropathologyEmily Feneberg, Martin R Turner, Olaf Ansorge, et al.
Toxins|October 24, 2020
Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron DiseaseMireia Herrando-Grabulosa, Caty Casas, Kevin Talbot, et al.
Nature Reviews. Neurology|February 10, 2018
Advances in therapy for spinal muscular atrophy: promises and challengesEwout J N Groen, Kevin Talbot, Thomas H Gillingwater
Journal of Neurology, Neurosurgery, and Psychiatry|November 11, 2011
Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage studyMartin R Turner, Clare Wotton, Kevin Talbot, et al.
Pageof 26

Showing results (41-50 of 255) with videos related to

Sort By:
Pageof 26
Expert Reviews in Molecular Medicine|July 21, 2010
The role of RNA processing in the pathogenesis of motor neuron degenerationDirk Bäumer, Olaf Ansorge, Mara Almeida, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|May 7, 2024
Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosisLara M Nikel, Kevin Talbot, Björn F Vahsen
Human Molecular Genetics|October 5, 2017
Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscapeMatthew J A Wood, Kevin Talbot, Melissa Bowerman
Journal of Neurology, Neurosurgery, and Psychiatry|September 14, 2021
Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosisAlexander G Thompson, Kevin Talbot, Martin R Turner
Trends in Neurosciences|February 16, 2010
GARS axonopathy: not every neuron's cup of tRNAWilliam W Motley, Kevin Talbot, Kenneth H Fischbeck
Practical Neurology|August 19, 2017
Fundus fluorescein angiography in Susac's syndromeGavin L Reynolds, Kevin Talbot, Srilakshmi M Sharma
Neurology|August 10, 2020
Amyotrophic lateral sclerosis with a heterozygous D91A SOD1 variant and classical ALS-TDP neuropathologyEmily Feneberg, Martin R Turner, Olaf Ansorge, et al.
Toxins|October 24, 2020
Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron DiseaseMireia Herrando-Grabulosa, Caty Casas, Kevin Talbot, et al.
Nature Reviews. Neurology|February 10, 2018
Advances in therapy for spinal muscular atrophy: promises and challengesEwout J N Groen, Kevin Talbot, Thomas H Gillingwater
Journal of Neurology, Neurosurgery, and Psychiatry|November 11, 2011
Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage studyMartin R Turner, Clare Wotton, Kevin Talbot, et al.
Pageof 26